National Biomedical Research Act
USA116th CongressHR-5400| House
| Updated: 12/12/2019
Yvette D. Clarke
Democratic Representative
New York
Cosponsors (1)
Rules Committee, Health Subcommittee, Energy and Commerce Committee, Budget Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
National Biomedical Research Act This bill establishes and makes deposits into the Biomedical Innovation Fund for initiatives at the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) for advancing medical innovation, including by supporting (1) research for disease prevention, diagnosis, and treatment; (2) research for diseases that disproportionally account for federal health care spending; (3) the development, review, and post-market surveillance of medical products; (4) early-career scientists, including researchers from traditionally underrepresented groups; and (5) other innovative research. The bill also requries annual reporting about the fund by the NIH, the FDA, and the Department of the Treasury.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Rules, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Health
Administrative law and regulatory proceduresAgingAppropriationsBudget deficits and national debtCancerChild healthComputers and information technologyDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationDrug therapyEducation programs fundingEnvironmental healthExecutive agency funding and structureFood and Drug Administration (FDA)GeneticsGovernment trust fundsHealth care costs and insuranceHealth information and medical recordsHealth personnelHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesImmunology and vaccinationMedicaidMedical educationMedical researchMedical tests and diagnostic methodsMedicareMilitary medicineMinority healthNational Institutes of Health (NIH)Neurological disordersNutrition and dietPhysical fitness and lifestylePoverty and welfare assistanceResearch administration and funding
National Biomedical Research Act
USA116th CongressHR-5400| House
| Updated: 12/12/2019
National Biomedical Research Act This bill establishes and makes deposits into the Biomedical Innovation Fund for initiatives at the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) for advancing medical innovation, including by supporting (1) research for disease prevention, diagnosis, and treatment; (2) research for diseases that disproportionally account for federal health care spending; (3) the development, review, and post-market surveillance of medical products; (4) early-career scientists, including researchers from traditionally underrepresented groups; and (5) other innovative research. The bill also requries annual reporting about the fund by the NIH, the FDA, and the Department of the Treasury.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Rules, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Yvette D. Clarke
Democratic Representative
New York
Cosponsors (1)
Rules Committee, Health Subcommittee, Energy and Commerce Committee, Budget Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Administrative law and regulatory proceduresAgingAppropriationsBudget deficits and national debtCancerChild healthComputers and information technologyDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationDrug therapyEducation programs fundingEnvironmental healthExecutive agency funding and structureFood and Drug Administration (FDA)GeneticsGovernment trust fundsHealth care costs and insuranceHealth information and medical recordsHealth personnelHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesImmunology and vaccinationMedicaidMedical educationMedical researchMedical tests and diagnostic methodsMedicareMilitary medicineMinority healthNational Institutes of Health (NIH)Neurological disordersNutrition and dietPhysical fitness and lifestylePoverty and welfare assistanceResearch administration and funding